Cargando…

Castleman disease mimicking systemic lupus erythematosus: A case report

RATIONALE: Castleman disease (CD) is a nonclonal lymphoproliferative disorder sometimes manifested systemic inflammatory symptoms. Systemic lupus erythematosus (SLE) is an autoimmune disease characterized with multi-system involvement as well as broad spectrum of serum autoantibodies. When these two...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li, Chen, Hua, Shi, Jing, Tang, Hao, Li, Hang, Zheng, Wenjie, Zhang, Fengchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160051/
https://www.ncbi.nlm.nih.gov/pubmed/30235674
http://dx.doi.org/10.1097/MD.0000000000012291
_version_ 1783358687725748224
author Wang, Li
Chen, Hua
Shi, Jing
Tang, Hao
Li, Hang
Zheng, Wenjie
Zhang, Fengchun
author_facet Wang, Li
Chen, Hua
Shi, Jing
Tang, Hao
Li, Hang
Zheng, Wenjie
Zhang, Fengchun
author_sort Wang, Li
collection PubMed
description RATIONALE: Castleman disease (CD) is a nonclonal lymphoproliferative disorder sometimes manifested systemic inflammatory symptoms. Systemic lupus erythematosus (SLE) is an autoimmune disease characterized with multi-system involvement as well as broad spectrum of serum autoantibodies. When these two conditions happened to have similar clinical spectrum features, the confusion with each other occurred. PATIENT CONCERNS: A 46-year-old man suffered from chronic fever, nephrotic syndrome, acute kidney injury, anemia, thrombocytopenia and serositis, as well as hypocomplementemia and negative anti-nuclear antibody. DIAGNOSES: Meeting the classification criteria for SLE, the patient was diagnosed as SLE at first. The renal biopsy showed that he had endocapillary proliferative glomerulonephritis with negative immunofluorescence. Finally, he was diagnosed with CD after lymph nodes biopsy. INTERVENTIONS: The patient was treated with oral prednisone (50 mg daily) but got poor response. After being proved to have CD, he was treated with CHOP chemotherapy. OUTCOMES: His condition was controlled by CHOP chemotherapy. After six course of chemotherapy, the proteinuria disappeared. LESSONS: If patients, even qualified by classification criteria of SLE, had negative autoantibody or unsatisfied response to the standard treatment, the original diagnosis should be suspected. The biopsy may be help to identify the final criminals, such as CD.
format Online
Article
Text
id pubmed-6160051
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-61600512018-10-12 Castleman disease mimicking systemic lupus erythematosus: A case report Wang, Li Chen, Hua Shi, Jing Tang, Hao Li, Hang Zheng, Wenjie Zhang, Fengchun Medicine (Baltimore) Research Article RATIONALE: Castleman disease (CD) is a nonclonal lymphoproliferative disorder sometimes manifested systemic inflammatory symptoms. Systemic lupus erythematosus (SLE) is an autoimmune disease characterized with multi-system involvement as well as broad spectrum of serum autoantibodies. When these two conditions happened to have similar clinical spectrum features, the confusion with each other occurred. PATIENT CONCERNS: A 46-year-old man suffered from chronic fever, nephrotic syndrome, acute kidney injury, anemia, thrombocytopenia and serositis, as well as hypocomplementemia and negative anti-nuclear antibody. DIAGNOSES: Meeting the classification criteria for SLE, the patient was diagnosed as SLE at first. The renal biopsy showed that he had endocapillary proliferative glomerulonephritis with negative immunofluorescence. Finally, he was diagnosed with CD after lymph nodes biopsy. INTERVENTIONS: The patient was treated with oral prednisone (50 mg daily) but got poor response. After being proved to have CD, he was treated with CHOP chemotherapy. OUTCOMES: His condition was controlled by CHOP chemotherapy. After six course of chemotherapy, the proteinuria disappeared. LESSONS: If patients, even qualified by classification criteria of SLE, had negative autoantibody or unsatisfied response to the standard treatment, the original diagnosis should be suspected. The biopsy may be help to identify the final criminals, such as CD. Wolters Kluwer Health 2018-09-21 /pmc/articles/PMC6160051/ /pubmed/30235674 http://dx.doi.org/10.1097/MD.0000000000012291 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Research Article
Wang, Li
Chen, Hua
Shi, Jing
Tang, Hao
Li, Hang
Zheng, Wenjie
Zhang, Fengchun
Castleman disease mimicking systemic lupus erythematosus: A case report
title Castleman disease mimicking systemic lupus erythematosus: A case report
title_full Castleman disease mimicking systemic lupus erythematosus: A case report
title_fullStr Castleman disease mimicking systemic lupus erythematosus: A case report
title_full_unstemmed Castleman disease mimicking systemic lupus erythematosus: A case report
title_short Castleman disease mimicking systemic lupus erythematosus: A case report
title_sort castleman disease mimicking systemic lupus erythematosus: a case report
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160051/
https://www.ncbi.nlm.nih.gov/pubmed/30235674
http://dx.doi.org/10.1097/MD.0000000000012291
work_keys_str_mv AT wangli castlemandiseasemimickingsystemiclupuserythematosusacasereport
AT chenhua castlemandiseasemimickingsystemiclupuserythematosusacasereport
AT shijing castlemandiseasemimickingsystemiclupuserythematosusacasereport
AT tanghao castlemandiseasemimickingsystemiclupuserythematosusacasereport
AT lihang castlemandiseasemimickingsystemiclupuserythematosusacasereport
AT zhengwenjie castlemandiseasemimickingsystemiclupuserythematosusacasereport
AT zhangfengchun castlemandiseasemimickingsystemiclupuserythematosusacasereport